Committed to supporting independent clinical research

Stryker’s Investigator Initiated Study (IIS) Grants are a part of our commitment to making healthcare better for our customers and their patients.

 

Your independent research studies are a crucial component in making healthcare better

Stryker helps advance clinical research by supporting independent investigator led research studies

Why partner with Stryker?

Stryker provides support in the form of monetary funding or supply of product(s) to ethical independent clinical research conducted by suitably qualified investigators.
An investigator-initiated study is a research protocol designed and implemented by the principal investigator (PI). The PI acts as the study sponsor responsible for understanding and complying with all regulatory requirements related to the study.

This partnership with independent research investigators is key to our continued commitment in improve healthcare and address unmet clinical needs.

Direct monetary fund

Supply of product(s)

Investigator Initiated Study (IIS) Program guidelines

Who can apply?

We’re looking for professionals or faculty members at an accredited medical or educational institution (applicants with previous research experience and publication history preferred).

Study criteria

  • Based on Stryker’s products with clinically relevant outcomes
  • Can be an observational, interventional or basic science study
  • Access to appropriate facilities and resources to conduct the proposed research
  • Rigorous research protocol/journal quality standards
  • Must be on-label

The IIS Program generally does not provide support for studies that involve investigational/pre-cleared/pre-market devices or off-label use of product.

Solve a clinical problem/need

Clinical observations requiring investigation

Sonopet/Pulse Control & Blood Loss

Cognitive Load and AI/CGI

Retrospective Allograft Bone Fusion Study with economic value

2022-2023 funding calls

Round 1
Application open ……………………………….……. August 01 – September 30
Review ………………………………………………… October 01 – November 15
Announcement ……………………………………….. December 01-15

Program process

1

Expression of interest

  • Proposal overview
  • Estimate budget
  • Investigator CV
2

Clinical council review

  • Review within 30 days
  • Initial approval to proceed 
  • Rejection with request to review and resubmit
  • Rejection
3

Submission of full protocol

  • Full review
  • Contract negotiation
  • Research agreement
  • Funding schedule
  • Milestone agreement
4

Full study approval

  • Study initiated 
  • Support provided as per agreement 
  • Agreed milestones achieved
  • Full peer review publication 

Request additional information

Complete the form to ask questions or let to let us know that you are interested. We’d love to help you get started.

Lisa O’Sullivan

Lisa O’Sullivan
Clinical Research Portfolio Manager

Bradley Allen

Bradley Allen
Clinical Research Manager

Ilka Meinert

Ilka Meinert
Associate Clinical Research Manager